NEW YORK, July 27, 2023: Morgan Lewis is representing Ayala Pharmaceuticals Inc. in its merger agreement with Biosight Ltd.
Ayala Pharmaceuticals is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. Biosight is a clinical-stage biotech company developing innovative therapeutics for hematological malignancies and disorders.
Partner Robert Dickey and associate Samuel Worth are advising Ayala Pharmaceuticals, along with partners Justin Chairman and Richard Zarin, and associates Fannie Law, Lily Teague, Nicholas Bekele, David Bionghi, and Jared Sanders.